Pei Wan

Meizhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Transcriptomic Profiles for Elucidating Response of Bladder Intracavitary Hyperthermic Perfusion Chemotherapy in High-Risk Nonmuscular Invasive Bladder Cancer.

Transcriptomic Profiles for Elucidating Response of Bladder Intracavitary Hyperthermic Perfusion Chemotherapy in High-Risk Nonmuscular Invasive Bladder Cancer.

Journal: Cancer medicine

Published: August 26, 2023

miR-200a-3p facilitates bladder cancer cell proliferation by targeting the A20 gene.

miR-200a-3p facilitates bladder cancer cell proliferation by targeting the A20 gene.

Journal: Translational andrology and urology

Published: October 07, 2021

Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro.

Upregulation of TMEM45A Promoted the Progression of Clear Cell Renal Cell Carcinoma in vitro.

Journal: Journal of inflammation research

Published: September 27, 2021

Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma.

Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma.

Journal: PeerJ

Published: April 21, 2021

Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.

Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.

Journal: Genomics

Published: February 04, 2021

Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.

Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.

Journal: Aging

Published: June 19, 2020

BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.

BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.

Journal: Oncology reports

Published: March 25, 2020

Eupatilin Inhibits Renal Cancer Growth by Downregulating MicroRNA-21 through the Activation of YAP1.

Eupatilin Inhibits Renal Cancer Growth by Downregulating MicroRNA-21 through the Activation of YAP1.

Journal: BioMed research international

Published: November 23, 2018

Norcantharidin inhibits pre-replicative complexes assembly of HepG2 cells.

Norcantharidin inhibits pre-replicative complexes assembly of HepG2 cells.

Journal: The American journal of Chinese medicine

Published: May 29, 2013

A meta-analysis of fish intake and the risk of renal cell cancer

A meta-analysis of fish intake and the risk of renal cell cancer

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Published: May 22, 2013

Norcantharidin inhibits DNA replication and induces mitotic catastrophe by degrading initiation protein Cdc6.

Norcantharidin inhibits DNA replication and induces mitotic catastrophe by degrading initiation protein Cdc6.

Journal: International journal of molecular medicine

Published: February 11, 2013

Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE).

Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE).

Journal: Journal of proteomics

Published: June 10, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026